Caplin Point Share Jumps 10% After Arm Gets USFDA Approval for Anti-Inflammatory Drug
Shares of Caplin Point rose more than 10% to Rs 709 per share in Friday’s intraday trade after the United States Food and Drug Administration...
Download Unicorn Signals App
Powered By EquityPandit
